Matinas BioPharma publishes updated corporate presentation

Matinas BioPharma (MTNB) has provided an update.

The Company has updated its corporate presentation for use at upcoming conferences and investor meetings. This important information tool, which is central to anyone interested in the Company's performance and prospects, is intended to provide a comprehensive overview of the Company's activities and is not considered a required filing under applicable securities laws, but is for informational purposes only.

For more information about MTNB shares, please visit TipRanks' Stock Analysis Page.